Full Product Name
Anti-BTBD9 Antibody (aa244-273) IHC-plus
Product Synonym Names
Rabbit Polyclonal to Human BTBD9; Human BTBD9; BTB (POZ) domain containing 9; DJ322I12.1; KIAA1880
Product Gene Name
anti-BTBD9 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for Q96Q07
Species Reactivity
Mouse, Human
Purity/Purification
Immunoaffinity purified
Form/Format
PBS, 0.09% sodium azide
Immunogen
BTBD9 antibody was raised against kLH-conjugated synthetic peptide from internal region of human BTBD9.
Immunogen Description
KLH-conjugated synthetic peptide from internal region of human BTBD9.
Immunogen Type
Synthetic peptide
Antigen Modification
aa244-273
Preparation and Storage
Maintain refrigerated at 2-8 degree C for up to 6 months.
For long term storage store at -20 degree C.
Other Notes
Small volumes of anti-BTBD9 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-BTBD9 antibody
BTBD9 Antibody, BTB (POZ) domain containing 9 Antibody, DJ322I12.1 Antibody, KIAA1880 Antibody Description: This locus encodes a BTB/POZ domain-containing protein. This domain is known to be involved in protein-protein interactions. Polymorphisms at this locus have been reported to be associated with susceptibility to Restless Legs Syndrome and may also be associated with Tourette Syndrome. Alternatively spliced transcript variants have been described.
Applications Tested/Suitable for anti-BTBD9 antibody
Immunohistochemistry (IHC) Paraffin, Western Blot (WB), Flow Cytometry (FC/FACS)
Application Notes for anti-BTBD9 antibody
Flow Cytometry (1:10 - 1:50)
IHC-P (1:100)
WB (1:1000)
Immunohistochemistry (IHC) of anti-BTBD9 antibody
Human Lung: Formalin-Fixed, Paraffin-Embedded (FFPE)
Immunohistochemistry (IHC) of anti-BTBD9 antibody
Human Small Intestine: Formalin-Fixed, Paraffin-Embedded (FFPE)
Western Blot (WB) of anti-BTBD9 antibody
BTBD9 Antibody western blot of Jurkat cell line lysates (15 ug/lane). The BTBD9 antibody detected the BTBD9 protein (arrow).
Flow Cytometry (FC/FACS) of anti-BTBD9 antibody
BTBD9 Antibody flow cytometry of Jurkat cells (bottom histogram) compared to a negative control cell (top histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.
NCBI/Uniprot data below describe general gene information for BTBD9. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001092742.1
[Other Products]
NCBI GenBank Nucleotide #
NM_001099272.1
[Other Products]
UniProt Primary Accession #
Q96Q07
[Other Products]
UniProt Secondary Accession #
Q494V9; Q494W1; Q96M00[Other Products]
UniProt Related Accession #
Q96Q07[Other Products]
Molecular Weight
61,558 Da
NCBI Official Full Name
BTB/POZ domain-containing protein 9 isoform a
NCBI Official Synonym Full Names
BTB domain containing 9
NCBI Official Symbol
BTBD9??[Similar Products]
NCBI Official Synonym Symbols
dJ322I12.1
??[Similar Products]
NCBI Protein Information
BTB/POZ domain-containing protein 9
UniProt Protein Name
BTB/POZ domain-containing protein 9
Protein Family
BTB/POZ domain-containing protein
UniProt Gene Name
BTBD9??[Similar Products]
UniProt Synonym Gene Names
KIAA1880??[Similar Products]
UniProt Entry Name
BTBD9_HUMAN
NCBI Summary for BTBD9
This locus encodes a BTB/POZ domain-containing protein. This domain is known to be involved in protein-protein interactions. Polymorphisms at this locus have been reported to be associated with susceptibility to Restless Legs Syndrome and may also be associated with Tourette Syndrome. Alternatively spliced transcript variants have been described. [provided by RefSeq, Aug 2011]
UniProt Comments for BTBD9
BTBD9: Genetic variations in BTBD9 may be associated with susceptibility to restless legs syndrome type 6 (RLS6); also called periodic limb movements in sleep. Restless legs syndrome (RLS) is a neurologic disorder characterized by an uncontrollable urge to move the legs during periods of rest. The majority of patients with RLS also have periodic limb movements in sleep, which are characterized by involuntary, highly stereotypical, regularly occurring limb movements that occur during sleep. 3 isoforms of the human protein are produced by alternative splicing.
Protein type: Unknown function
Chromosomal Location of Human Ortholog: 6p21
Biological Process: ***** locomotory behavior; circadian sleep/wake cycle, non-REM sleep; long-term memory; sensory perception of temperature stimulus; serotonin metabolic process
Disease: Restless Legs Syndrome, Susceptibility To, 6
Research Articles on BTBD9
1. The results of this study BTBD9 suggest that the examined BTBD9 variants are not associated with GTS risk, but may be associated with comorbidity and tic severity in the Polish population.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
